A long-lasting treatment for knee osteoarthritis (OA)

Arthrosamid^® is a non-biodegradable 2.5% iPAAG injectable implant – The first and only synovial scaffold administered in single outpatient procedure, improving the quality of life for patients with knee OA.

Arthrosamid^® received European approval in 2021 following the completion of a clinical study demonstrating significant pain reduction in patients with knee OA, redefining treatment for knee OA, without surgery.

Arthrosamid^® is a safe and minimally invasive treatment, addressing an unmet need, which may prevent or postpone the need for knee surgery. It is a single injection that provides long-lasting pain relief.

Visit Arthrosamid^® website to read our latest clinical data that shows symptom relief out to 3 years.